Daneshmand S, Zaucha R, Catto JWF, Tran B, et al. Erdafitinib in Patients with High- and Intermediate-risk Non-muscle-invasive Bladder Cancer: Final Analysis of THOR-2 Study. Eur Urol 2025 Oct 7:S0302-2838(25)04702-5. doi: 10.1016/j.eururo.2025.09.4152.
PMID: 41062389